Tips for starting a peer education program for inmates. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Tips for starting a peer education program for inmates. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

AIDS Policy Law. 1997 Apr 18;12(7):8-9. Unique Identifier : AIDSLINE AIDS/97702525


Abstract: Peer education programs have met with some success in changing HIV risk behaviors in the prison setting. Peer educators effectively communicate with other inmates about how the virus is spread and what can be done to reduce the risk of infection. Properly trained, peer educators may be more credible and relevant with inmates. Prisons can initiate a peer education program with the help of outside AIDS service agencies, through grant opportunities, and by establishing links with prison advocacy groups. The language and cultural differences in prison populations should be considered. Prison officials should recruit a mix of HIV-positive individuals, HIV-negative individuals, and those with a history of injection drug use to be trained for the peer educator positions.
Keywords: Counseling Female HIV Infections/*PREVENTION & CONTROL Health Education/ECONOMICS/*METHODS Human Male Peer Group *Prisoners Prisons/*ORGANIZATION & ADMIN United States NEWSLETTER ARTICLEKWDcounselingfemalehivinfections/KWDprevention&controlhealtheducation/economics/KWDmethodshumanmalepeergroupKWDprisonersprisons/KWDorganization&adminunitedstatesnewsletterarticle
970830
M9781226

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .